Workflow
安全性风险收益评估
icon
Search documents
Lexeo Therapeutics (LXEO) 2025 Conference Transcript
2025-09-03 14:12
Lexeo Therapeutics (LXEO) 2025 Conference September 03, 2025 09:10 AM ET Company ParticipantsJosh Schimmer - Managing DirectorR. Nolan Townsend - CEO & DirectorEric Adler - Chief Medical Officer & Head of ResearchJosh SchimmerWelcome, everyone. I'm Josh Shumer from the Kantar Biotech Equity Research Team. Welcome to the Kantar Global Healthcare Conference. Very pleased to introduce the management team from Lexeo Therapeutics. We have R. Nolan Townsend, Chief Executive Officer, Eric Adler, Chief Medical Offi ...